Renk's Two-Speed Reality: A €7.4 Billion Backlog Collides With a Halved Share Price

Renk's €7.4B order book and capacity expansion contrast with 35% share drop; analysts split on 2026 trough and margin outlook.

The arithmetic at Renk Group is hard to square. The Augsburg-based defence supplier carries a corporate order book worth €7.4 billion, its vehicle mobility division alone accounts for €2.2 billion of that with another €3.5 billion to €4 billion in the pipeline, and production targets are being ratcheted up aggressively toward the end of the decade. Yet the shares trade at roughly half the record high they set in October 2025, and the analyst community that gathered around the stock this week could not agree on what comes next.

Morgan Stanley opened coverage on Monday with an "Equal-Weight" rating and a €50 price target, a stance best described as constructive caution. Bankhaus Metzler struck a far more bullish chord the same day, setting its target at €75 and arguing that the second quarter of 2026 will mark the operational trough, with margins set to climb structurally through 2030. The market's initial response was mildly positive — the stock gained 4.0 percent on Tuesday to €44.62, having closed the prior session at €42.89 — but the move did little to alter a technical picture that remains firmly bearish.

Twelve-month losses stand at 35 percent, and the shares have shed 17 percent since the start of the year. At its worst point, the stock touched €40.41, its 52-week low, and it still sits roughly 4.9 percent below its 50-day moving average and 14 percent under its 200-day average. The distance from the October peak of €90.20 is stark, and the annualised volatility of 34 percent suggests investors should brace for further erratic swings.

The Capacity Question

The central tension for investors is whether Renk can convert its bulging backlog into profitable revenue growth, or whether margin pressure will continue to throttle the story. The first-half numbers offer evidence for both readings. Revenue reached €637.2 million with an EBIT margin of 15.4 percent — respectable on the surface — but the second quarter told a less flattering tale. Earnings per share fell to €0.15 from €0.30 a year earlier, while revenue managed only a 1.74 percent advance to €353.59 million.

Management's guidance for 2026 points to revenue above €1.5 billion and EBIT in a range of €255 million to €285 million, but the gap between a well-stuffed order book and a deteriorating quarterly profit raises uncomfortable questions about supply chains, ramp-up costs and pricing pressure.

The company's response has been to invest its way out of the bottleneck. Over the weekend, Renk announced a capacity expansion in Augsburg, and the shares have ticked up 1.3 percent since. The broader plan involves lifting production of tank gearboxes from more than 800 units this year to over 2,000 by 2030, more than tripling annual transmission output. Germany will absorb up to €325 million in digitalisation and capacity spending through 2028, with a further €20 million-plus earmarked for the Rheine site. The logic, as Morgan Stanley sees it, is that these investments lay the groundwork for revenue jumps once defence orders are actually called off.

Institutional Moves and a Split Verdict

The shareholder register has been active of late. Wellington Management Group crossed the five-percent threshold just over a week ago, after which the stock gave back 1.4 percent. BlackRock subsequently raised its attributed voting rights to 3.11 percent, with a combined stake of 4.18 percent including instruments. These filings point to growing institutional interest in the defence name, though they have not generated meaningful price momentum.

The order intake figures from August remain the strongest pillar of the bull case: new orders climbed 29.7 percent to €1.2 billion in the first half, while adjusted EBIT rose 10.1 percent to €98 million. Metzler's scenario rests on the assumption that the second quarter marked the low point and that margins will improve structurally as scale effects from the capacity build-out kick in. The consensus price target of €66.86, with a range of €60 to €75, sits well above the current level — a signal that the market is pricing in operational substance that has yet to show up in the share price.

The bears, however, can point to the technicals and the cautious stance from Morgan Stanley as evidence that the downtrend is not yet broken. With a market capitalisation of €4.32 billion and an RSI of 37.3, the stock shows signs of selling exhaustion without being technically oversold. The next genuine test arrives with the upcoming quarterly figures, which will determine whether Metzler's predicted trough actually materialises or whether the margin weakness proves more structural than cyclical.